SB Paxil Exclusivity Defense: Synthon Files NDA For Paroxetine Mesylate

SmithKline Beecham could face competition to its antidepressant Paxil in the U.S. from an NDAed version of a different salt of paroxetine filed by Synthon.

More from Archive

More from Pink Sheet